Insulet (PODD) Reports In-Line Q1 EPS

Insulet (NASDAQ: PODD) reported Q1 EPS of ($0.19), inline with the analyst estimate. Revenue for the quarter came in at $81.2 million versus the consensus estimate of $79.06 million.

GUIDANCE:

Insulet sees Q2 2016 revenue of $81-84 million, versus the consensus of $82.3 million.

• For the year ending December 31, 2016, the Company is reaffirming its revenue guidance of $330 to $350 million

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• FDA: classifies Insulet OmniPod pods recall as Class I due to serious injury risk
• Lucid reports Q2 output, names new CFO and five other leaders
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform